BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Plantinga LC, Crews DC, Coresh J, Miller ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol. 2010;5:673-682. [PMID: 20338960 DOI: 10.2215/cjn.07891109] [Cited by in Crossref: 246] [Cited by in F6Publishing: 262] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Guney SC, Cay Y, Yildirim Simsir I, Kabaroglu C, Afrashi F, Saygili LF. The prevalence and risk factors of retinopathy and nephropathy in prediabetic population. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-022-01105-z] [Reference Citation Analysis]
2 Sneed NM, Azuero A, Moss J, Goss AM, Morrison SA. Total Added Sugar Consumption is not Significantly Associated with Risk for Prediabetes Among U.S. adults: National Health and Nutrition Examination Survey, 2013-2018.. [DOI: 10.1101/2022.08.22.22279065] [Reference Citation Analysis]
3 Hung C, Zhen Y, Niu S, Lin K, Lin HY, Lee J, Chang J, Kuo I. Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients. Biomedicines 2022;10:1858. [DOI: 10.3390/biomedicines10081858] [Reference Citation Analysis]
4 Niyi-odumosu F. Associations of Physical Activity, Kidney Function, Diet, and Inflammatory Markers in High-Risk Type-2 Diabetes With Early-Stage Chronic Kidney Disease (CKD). Asian J Kinesiol 2022;24:3-12. [DOI: 10.15758/ajk.2022.24.3.3] [Reference Citation Analysis]
5 Aboolian A, Urner S, Roden M, Jha JC, Jandeleit-Dahm K. Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities. Handb Exp Pharmacol 2022;274:269-307. [PMID: 35318511 DOI: 10.1007/164_2021_576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gottwald-Hostalek U, Gwilt M. Vascular complications in prediabetes and type 2 diabetes: a continuous process arising from a common pathology. Curr Med Res Opin 2022;:1-30. [PMID: 35833523 DOI: 10.1080/03007995.2022.2101805] [Reference Citation Analysis]
7 Bashkinov RA, Batluk TI, Melnikov ES, Trubnikova MA, Arutyunov AG. Influence of metabolic disorders on the development of renal pathology. jour 2022;3:7-18. [DOI: 10.21886/2712-8156-2022-3-2-7-18] [Reference Citation Analysis]
8 Özen Y, Özeke Ö, Özbay MB, Açar B, Karakurt M, Kuyumcu MS, Gayretli Yayla K, Yayla Ç, Ertem A, Aras D. İlk tanı akut koroner sendrom ile başvuran hastalarda koroner arter çaplarının prediyabet ve diyabet ile ilişkisinin incelenmesi. Turkish Journal of Clinics and Laboratory 2022. [DOI: 10.18663/tjcl.1113964] [Reference Citation Analysis]
9 Shahzadi A, Sonmez I, Kose C, Oktan B, Alagoz S, Sonmez H, Hussain A, Akkan AG. The Prevalence of Potential Drug-Drug Interactions in CKD-A Retrospective Observational Study of Cerrahpasa Nephrology Unit. Medicina 2022;58:183. [DOI: 10.3390/medicina58020183] [Reference Citation Analysis]
10 Yamada S, Inaba M. Diabetes and Bone. Osteoporotic Fracture and Systemic Skeletal Disorders 2022. [DOI: 10.1007/978-981-16-5613-2_18] [Reference Citation Analysis]
11 Jayanama K, Phuphuakrat A, Pongchaikul P, Prombutara P, Nimitphong H, Reutrakul S, Sungkanuparph S. Association between gut microbiota and prediabetes in people living with HIV. Current Research in Microbial Sciences 2022;3:100143. [DOI: 10.1016/j.crmicr.2022.100143] [Reference Citation Analysis]
12 Kohlenberg J, Vella A. “Is Prediabetes a Risk Factor or Is It a Disease?”. Clinical Dilemmas in Diabetes 2021. [DOI: 10.1002/9781119603207.ch1] [Reference Citation Analysis]
13 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
14 Kim JM, Joung KH, Lee JC, Choung S, Kang SM, Kim HJ, Ku BJ. Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus. Ann Transl Med 2021;9:1612. [PMID: 34926656 DOI: 10.21037/atm-21-3272] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Liu Y, Guo H, Wang Q, Chen J, Xuan Y, Xu J, Liu Y, Sun K, Gao Q, Sun Z, Wang B. Short-term effects of lifestyle intervention in the reversion to normoglycemia in people with prediabetes. Prim Care Diabetes 2021:S1751-9918(21)00225-4. [PMID: 34930688 DOI: 10.1016/j.pcd.2021.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Fukuma S, Sasaki S, Taguri M, Goto R, Misumi T, Saigusa Y, Tsugawa Y. Effect of Nudge-Based Intervention on Adherence to Physician Visit Recommendations and Early Health Outcomes among Individuals Identified with Chronic Kidney Disease in Screens. J Am Soc Nephrol 2022;33:175-85. [PMID: 34903568 DOI: 10.1681/ASN.2021050664] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Handelsman Y, Anderson JE, Bakris GL, Ballantyne CM, Beckman JA, Bhatt DL, Bloomgarden ZT, Bozkurt B, Budoff MJ, Butler J, Dagogo-Jack S, de Boer IH, DeFronzo RA, Eckel RH, Einhorn D, Fonseca VA, Green JB, Grunberger G, Guerin C, Inzucchi SE, Jellinger PS, Kosiborod MN, Kushner P, Lepor N, Mende CW, Michos ED, Plutzky J, Taub PR, Umpierrez GE, Vaduganathan M, Weir MR. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications 2021;:108101. [PMID: 34922811 DOI: 10.1016/j.jdiacomp.2021.108101] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Jiang C, Yang R, Kuang M, Yu M, Zhong M, Zou Y. Triglyceride glucose-body mass index in identifying high-risk groups of pre-diabetes. Lipids Health Dis 2021;20:161. [PMID: 34774061 DOI: 10.1186/s12944-021-01594-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Schroijen MA, de Mutsert R, Dekker FW, de Vries APJ, de Koning EJP, Rabelink TJ, Rosendaal FR, Dekkers OM. The association of glucose metabolism and kidney function in middle-aged adults. Clin Kidney J 2021;14:2383-90. [PMID: 34754434 DOI: 10.1093/ckj/sfab074] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Kang E, Park J, Kim HJ, Park S, Park M, Kim Y, Kim K, Park SM, Chae DW, Chin HJ, Lee JP, Lee S, Kim SW, Cho JH, Han M, Kim YC, Kim YS, Choi I, Lee H. Metabolic risks in living kidney donors in South Korea. Kidney Res Clin Pract 2021. [PMID: 34781645 DOI: 10.23876/j.krcp.20.271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Shilpasree AS, Patil VS, Revanasiddappa M, Patil VP, Ireshnavar D. Renal Dysfunction in Prediabetes: Confirmed by Glomerular Hyperfiltration and Albuminuria. J Lab Physicians 2021;13:257-62. [PMID: 34602791 DOI: 10.1055/s-0041-1731107] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
22 Wang D, Fang R, Han H, Zhang J, Chen K, Fu X, He Q, Yang Y. Association between visceral adiposity index and risk of prediabetes: A meta-analysis of observational studies. J Diabetes Investig 2021. [PMID: 34592063 DOI: 10.1111/jdi.13685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Yadav R, Jain N, Raizada N, Jhamb R, Rohatgi J, Madhu SV. Prevalence of diabetes related vascular complications in subjects with normal glucose tolerance, prediabetes, newly detected diabetes and known diabetes. Diabetes Metab Syndr 2021;15:102226. [PMID: 34303917 DOI: 10.1016/j.dsx.2021.102226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Li W, Wang A, Jiang J, Liu G, Wang M, Li D, Wen J, Mu Y, Du X, Gaisano H, Dou J, He Y. Risk of chronic kidney disease defined by decreased estimated glomerular filtration rate in individuals with different prediabetic phenotypes: results from a prospective cohort study in China. BMJ Open Diabetes Res Care 2020;8:e000955. [PMID: 32245825 DOI: 10.1136/bmjdrc-2019-000955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Landstra CP, de Koning EJP. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course. Front Endocrinol (Lausanne) 2021;12:649525. [PMID: 34220706 DOI: 10.3389/fendo.2021.649525] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 46.0] [Reference Citation Analysis]
26 Lian H, Wu H, Ning J, Lin D, Huang C, Li F, Liang Y, Qi Y, Ren M, Yan L, You L, Xu M. The Risk Threshold for Hemoglobin A1c Associated With Albuminuria: A Population-Based Study in China. Front Endocrinol (Lausanne) 2021;12:673976. [PMID: 34135862 DOI: 10.3389/fendo.2021.673976] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Moshkovits Y, Rott D, Chetrit A, Dankner R. The association between insulin sensitivity indices, ECG findings and mortality: a 40-year cohort study. Cardiovasc Diabetol 2021;20:97. [PMID: 33957929 DOI: 10.1186/s12933-021-01284-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Pal K, Horsfall L, Sharma M, Nazareth I, Petersen I. Time trends in the incidence of clinically diagnosed type 2 diabetes and pre-diabetes in the UK 2009-2018: a retrospective cohort study. BMJ Open Diabetes Res Care 2021;9:e001989. [PMID: 33741554 DOI: 10.1136/bmjdrc-2020-001989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
29 Zhou YL, Zhang YG, Zhang R, Zhou YL, Li N, Wang MY, Tian HM, Li SY. Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital. Chin Med J (Engl) 2021;134:1317-23. [PMID: 33734138 DOI: 10.1097/CM9.0000000000001407] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
30 Neves JS, Correa S, Baeta Baptista R, Bigotte Vieira M, Waikar SS, Mc Causland FR. Association of Prediabetes With CKD Progression and Adverse Cardiovascular Outcomes: An Analysis of the CRIC Study. J Clin Endocrinol Metab 2020;105:dgaa017. [PMID: 31943096 DOI: 10.1210/clinem/dgaa017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
31 Mustian MN, Kumar V, Locke JE. Evaluation of Metabolic and Cardiovascular Risks in Living Donor Candidates. Living Kidney Donation 2021. [DOI: 10.1007/978-3-030-53618-3_6] [Reference Citation Analysis]
32 Mise K. Nondiabetic Renal Disease (NDRD) and Diabetic Kidney Disease (DKD). Diabetic Kidney Disease 2021. [DOI: 10.1007/978-981-15-9301-7_12] [Reference Citation Analysis]
33 Pryor JB, Lockridge J, Olyaei AJ. The Principles of Drug Dosing in Peritoneal Dialysis. Applied Peritoneal Dialysis 2021. [DOI: 10.1007/978-3-030-70897-9_25] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Muanda FT, Weir MA, Bathini L, Clemens KK, Perkovic V, Sood MM, McArthur E, Sontrop JM, Kim RB, Garg AX. Higher-Dose Sitagliptin and the Risk of Congestive Heart Failure in Older Adults with CKD. Clin J Am Soc Nephrol 2020;15:1728-39. [PMID: 33239410 DOI: 10.2215/CJN.08310520] [Reference Citation Analysis]
35 Bruun-Rasmussen NE, Napolitano G, Kofoed-Enevoldsen A, Bojesen SE, Ellervik C, Rasmussen K, Jepsen R, Lynge E. Burden of prediabetes, undiagnosed, and poorly or potentially sub-controlled diabetes: Lolland-Falster health study. BMC Public Health 2020;20:1711. [PMID: 33198690 DOI: 10.1186/s12889-020-09791-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 Yu ES, Hong K, Chun BC. Incidence and risk factors of vascular complications in people with impaired fasting glucose: a national cohort study in Korea. Sci Rep 2020;10:19504. [PMID: 33177611 DOI: 10.1038/s41598-020-76661-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
37 Wen J, Wang A, Liu G, Wang M, Zuo Y, Li W, Zhai Q, Mu Y, Gaisano HY, He Y, Dou J. Elevated triglyceride-glucose (TyG) index predicts incidence of Prediabetes: a prospective cohort study in China. Lipids Health Dis 2020;19:226. [PMID: 33059672 DOI: 10.1186/s12944-020-01401-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
38 Baranowska-Jurkun A, Matuszewski W, Bandurska-Stankiewicz E. Chronic Microvascular Complications in Prediabetic States-An Overview. J Clin Med 2020;9:E3289. [PMID: 33066307 DOI: 10.3390/jcm9103289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
39 Tanabe H, Saito H, Machii N, Kudo A, Tanaka K, Asahi K, Kazama JJ, Shimabukuro M. Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study. J Clin Med 2020;9:E2028. [PMID: 32605211 DOI: 10.3390/jcm9072028] [Reference Citation Analysis]
40 Liu L, Gao B, Wang J, Yang C, Wu S, Wu Y, Chen S, Li Q, Zhang H, Wang G, Chen M, Zhao MH, Zhang L. Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes. J Diabetes Res. 2020;2020:2720905. [PMID: 32587865 DOI: 10.1155/2020/2720905] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Phuphuakrat A, Nimitphong H, Reutrakul S, Sungkanuparph S. Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors. AIDS Res Ther 2020;17:25. [PMID: 32448349 DOI: 10.1186/s12981-020-00284-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
42 Gabriel R, Boukichou Abdelkader N, Acosta T, Gilis-Januszewska A, Gómez-Huelgas R, Makrilakis K, Kamenov Z, Paulweber B, Satman I, Djordjevic P, Alkandari A, Mitrakou A, Lalic N, Colagiuri S, Lindström J, Egido J, Natali A, Pastor JC, Teuschl Y, Lind M, Silva L, López-Ridaura R, Tuomilehto J; e-PREDICE Consortium. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data. PLoS One 2020;15:e0231196. [PMID: 32282852 DOI: 10.1371/journal.pone.0231196] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
43 Pinchevsky Y, Butkow N, Raal FJ, Chirwa T, Rothberg A. Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature. Int J Gen Med 2020;13:121-9. [PMID: 32280262 DOI: 10.2147/IJGM.S226010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 10.5] [Reference Citation Analysis]
44 Bar-Tana J. Type 2 diabetes - unmet need, unresolved pathogenesis, mTORC1-centric paradigm. Rev Endocr Metab Disord 2020;21:613-29. [PMID: 32128655 DOI: 10.1007/s11154-020-09545-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
45 Tsuchida K, Mitsuma W, Sato Y, Ozaki K, Soda S, Hatada K, Tanaka K, Hosaka Y, Imai S, Takahashi K, Matsubara T, Oda H. Impaired glucose tolerance and future cardiovascular risk after coronary revascularization: a 10-year follow-up report. Acta Diabetol 2020;57:173-82. [PMID: 31375898 DOI: 10.1007/s00592-019-01394-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Wen J, Cai X, Zhang J, Jiang J, Li W, Liu G, Wang M, Gaisano HY, Pan Y, He Y. Relation of adipose tissue insulin resistance to prediabetes. Endocrine 2020;68:93-102. [PMID: 31925734 DOI: 10.1007/s12020-020-02186-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
47 Al Amri T, Bahijri S, Al-Raddadi R, Ajabnoor G, Al Ahmadi J, Jambi H, Borai A, Tuomilehto J. The Association Between Prediabetes and Dyslipidemia Among Attendants of Primary Care Health Centers in Jeddah, Saudi Arabia. Diabetes Metab Syndr Obes 2019;12:2735-43. [PMID: 31920353 DOI: 10.2147/DMSO.S233717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
48 Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries. Kidney Int Rep 2020;5:263-77. [PMID: 32154448 DOI: 10.1016/j.ekir.2019.12.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
49 Rathi N, Whelton PK, Chertow GM, Cushman WC, Cheung AK, Wei G, Boucher R, Kimmel PL, Bress AP, Kramer HJ, Al-Marji C, Greene T, Beddhu S. Influence of Prediabetes on the Effects of Intensive Systolic Blood Pressure Control on Kidney Events. Am J Hypertens 2019;32:1170-7. [PMID: 31257407 DOI: 10.1093/ajh/hpz105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Al-Rifai RH, Majeed M, Qambar MA, Ibrahim A, AlYammahi KM, Aziz F. Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018.Syst Rev. 2019;8:268. [PMID: 31703716 DOI: 10.1186/s13643-019-1187-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
51 Ichikawa O, Glicksberg BS, Minsky N, Lee H, Li SD, Chen R, Li L, Dudley JT. Identification and genetic validation of drug-comorbidity interactions in type 2 diabetes using data-driven disease trajectory analysis.. [DOI: 10.1101/814392] [Reference Citation Analysis]
52 F Branda JI, de Almeida-pititto B, Ferreira SRG. Prevalence of diabetic kidney disease in prediabetes. Obesity Medicine 2019;15:100105. [DOI: 10.1016/j.obmed.2019.100105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Mendez CE, Walker RJ, Eiler CR, Mishriky BM, Egede LE. Insulin therapy in patients with type 2 diabetes and high insulin resistance is associated with increased risk of complications and mortality. Postgrad Med 2019;131:376-82. [PMID: 31311382 DOI: 10.1080/00325481.2019.1643635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
54 Zhang H, Qi D, Gu H, Wang T, Wu Y, Li J, Ni J, Liu J, Tu J, Ning X, Wang J. Trends in the prevalence, awareness, treatment and control of diabetes in rural areas of northern China from 1992 to 2011. J Diabetes Investig 2020;11:241-9. [PMID: 31172682 DOI: 10.1111/jdi.13095] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
55 Sumbul HE, Koc AS, Gülümsek E. Renal cortical stiffness is markedly increased in pre-diabetes mellitus and associated with albuminuria. Singapore Med J 2020;61:435-42. [PMID: 31197376 DOI: 10.11622/smedj.2019052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
56 Vieira MB, Neves JS, Leitão L, Baptista RB, Magriço R, Dias CV, Oliveira A, Carvalho D, Mc Causland FR. Impaired Fasting Glucose and Chronic Kidney Disease, Albuminuria, or Worsening Kidney Function: a Secondary Analysis of the SPRINT. J Clin Endocrinol Metab 2019:jc. [PMID: 31063197 DOI: 10.1210/jc.2019-00073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
57 Asmelash D, Asmelash Y. The Burden of Undiagnosed Diabetes Mellitus in Adult African Population: A Systematic Review and Meta-Analysis. J Diabetes Res 2019;2019:4134937. [PMID: 31183383 DOI: 10.1155/2019/4134937] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
58 Damtie S, Biadgo B, Baynes HW, Ambachew S, Melak T, Asmelash D, Abebe M. Chronic Kidney Disease and Associated Risk Factors Assessment among Diabetes Mellitus Patients at A Tertiary Hospital, Northwest Ethiopia.Ethiop J Health Sci. 2018;28:691-700. [PMID: 30607085 DOI: 10.4314/ejhs.v28i6.3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
59 Bakiner OS, Bozkırlı E, Aksöyek A, Özşahin AK. Prediabetes: An Update and a Rational for Diagnostic Confusion. Turkish Journal of Family Medicine and Primary Care 2019. [DOI: 10.21763/tjfmpc.528045] [Reference Citation Analysis]
60 Hum JM, O'Bryan LM, Tatiparthi AK, Clinkenbeard EL, Ni P, Cramer MS, Bhaskaran M, Johnson RL, Wilson JM, Smith RC, White KE. Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy. J Appl Physiol (1985) 2019;126:854-62. [PMID: 30605400 DOI: 10.1152/japplphysiol.00838.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
61 Kelkar S, Muley S, Ambardekar P. Special Surgical Situations and Diabetes Management: Part 1. Towards Optimal Management of Diabetes in Surgery 2019. [DOI: 10.1007/978-981-13-7705-1_7] [Reference Citation Analysis]
62 Ali MK, Shah MK, Moin T. Diabetes Management in the United States. The Diabetes Textbook 2019. [DOI: 10.1007/978-3-030-11815-0_17] [Reference Citation Analysis]
63 Fagg J, Valabhji J. How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing? Diabet Med 2019;36:316-25. [PMID: 30466172 DOI: 10.1111/dme.13867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
64 Ahluwalia TS, Schulz CA, Waage J, Skaaby T, Sandholm N, van Zuydam N, Charmet R, Bork-Jensen J, Almgren P, Thuesen BH, Bedin M, Brandslund I, Christensen CK, Linneberg A, Ahlqvist E, Groop PH, Hadjadj S, Tregouet DA, Jørgensen ME, Grarup N, Pedersen O, Simons M, Groop L, Orho-Melander M, McCarthy MI, Melander O, Rossing P, Kilpeläinen TO, Hansen T. A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria. Diabetologia 2019;62:292-305. [PMID: 30547231 DOI: 10.1007/s00125-018-4783-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
65 Chen Z, Wu S, Huang J, Yuan J, Chen H, Chen Y. Metabolic syndrome increases cardiovascular risk in a population with prediabetes: A prospective study in a cohort of Chinese adults. J Diabetes Investig 2019;10:673-9. [PMID: 30312020 DOI: 10.1111/jdi.12958] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
66 Ustulin M, Rhee SY, Chon S, Ahn KK, Lim JE, Oh B, Kim SH, Baik SH, Park Y, Nam MS, Lee KW, Kim YS, Woo JT. Importance of family history of diabetes in computing a diabetes risk score in Korean prediabetic population. Sci Rep 2018;8:15958. [PMID: 30374195 DOI: 10.1038/s41598-018-34411-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
67 Tong YZ, Tong NW, Teng WP, Mu YM, Zhao JJ, Shan ZY, Ning G; Chinese Society of Endocrinology. Consensus on the Prevention of Type 2 Diabetes in Chinese Adults. Chin Med J (Engl) 2017;130:600-6. [PMID: 28229993 DOI: 10.4103/0366-6999.200532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
68 Zhao K, Yang SS, Wang HB, Chen K, Lu ZH, Mu YM. Association between the Hypertriglyceridemic Waist Phenotype and Prediabetes in Chinese Adults Aged 40 Years and Older. J Diabetes Res 2018;2018:1031939. [PMID: 30046615 DOI: 10.1155/2018/1031939] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
69 Siriwardhana C, Lim E, Davis J, Chen JJ. Progression of diabetes, ischemic heart disease, and chronic kidney disease in a three chronic conditions multistate model. BMC Public Health 2018;18:752. [PMID: 29914451 DOI: 10.1186/s12889-018-5688-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
70 Hieshima K, Suzuki T, Sugiyama S, Kurinami N, Yoshida A, Miyamoto F, Kajiwara K, Jinnouchi T, Jinnouchi H. Smoking Cessation Ameliorates Microalbuminuria With Reduction of Blood Pressure and Pulse Rate in Patients With Already Diagnosed Diabetes Mellitus. J Clin Med Res 2018;10:478-85. [PMID: 29707089 DOI: 10.14740/jocmr3400w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
71 Mihardja L, Delima D, Massie RGA, Karyana M, Nugroho P, Yunir E. Prevalence of kidney dysfunction in diabetes mellitus and associated risk factors among productive age Indonesian. J Diabetes Metab Disord 2018;17:53-61. [PMID: 29984211 DOI: 10.1007/s40200-018-0338-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
72 Toprak O, Kurt H, Sarı Y, Şarkış C, Us H, Kırık A. Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study. Kidney Blood Press Res 2017;42:33-42. [PMID: 28297698 DOI: 10.1159/000468530] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
73 Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis 2018;25:121-32. [PMID: 29580576 DOI: 10.1053/j.ackd.2017.10.011] [Cited by in Crossref: 176] [Cited by in F6Publishing: 188] [Article Influence: 44.0] [Reference Citation Analysis]
74 Daniele G, Winnier D, Mari A, Bruder J, Fourcaudot M, Pengou Z, Hansis-Diarte A, Jenkinson C, Tripathy D, Folli F. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans. Acta Diabetol 2018;55:139-48. [PMID: 29151224 DOI: 10.1007/s00592-017-1065-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
75 Møller G, Rikardt Andersen J, Ritz C, P Silvestre M, Navas-Carretero S, Jalo E, Christensen P, Simpson E, Taylor M, Martinez JA, Macdonald I, Swindell N, Mackintosh KA, Stratton G, Fogelholm M, Larsen TM, Poppitt SD, Dragsted LO, Raben A. Higher Protein Intake Is Not Associated with Decreased Kidney Function in Pre-Diabetic Older Adults Following a One-Year Intervention-A Preview Sub-Study. Nutrients 2018;10:E54. [PMID: 29315212 DOI: 10.3390/nu10010054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
76 Defronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_8-1] [Reference Citation Analysis]
77 Stacey RB, D'ambra V, Gjini P. Prediabetes: An Emerging Risk Factor for Coronary Artery Disease. Lifestyle in Heart Health and Disease 2018. [DOI: 10.1016/b978-0-12-811279-3.00022-7] [Reference Citation Analysis]
78 Defronzo RA. Pathogenesis of Type 2 Diabetes Mellitus. Endocrinology 2018. [DOI: 10.1007/978-3-319-45015-5_8] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
79 Warden CH, Bettaieb A, Min E, Fisler JS, Haj FG, Stern JS. Chow fed UC Davis strain female Lepr fatty Zucker rats exhibit mild glucose intolerance, hypertriglyceridemia, and increased urine volume, all reduced by a Brown Norway strain chromosome 1 congenic donor region. PLoS One 2017;12:e0188175. [PMID: 29211750 DOI: 10.1371/journal.pone.0188175] [Reference Citation Analysis]
80 Tentolouris N, Eleftheriadou I. Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the NHANES trial. Hellenic J Cardiol 2017;58:348-9. [PMID: 29203162 DOI: 10.1016/j.hjc.2017.11.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
81 Cefalu WT. "Prediabetes": Are There Problems With This Label? No, We Need Heightened Awareness of This Condition! Diabetes Care 2016;39:1472-7. [PMID: 27457639 DOI: 10.2337/dc16-1143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
82 Aladeniyi I, Adeniyi OV, Fawole O, Adeolu M, Ter Goon D, Ajayi AI, Iruedo J. The Prevalence and Correlates of Pre-Diabetes and Diabetes Mellitus Among Public Category Workers in Akure, Nigeria. TOPHJ 2017;10:167-76. [DOI: 10.2174/1874944501710010167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
83 Larsen AU, Grimnes G, Jorde R. The effect of high-dose vitamin D<sub>3</sub> supplementation on bone mineral density in subjects with prediabetes. Osteoporos Int. 2018;29:171-180. [PMID: 28921338 DOI: 10.1007/s00198-017-4222-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
84 Tan J, Zwi LJ, Collins JF, Marshall MR, Cundy T. Presentation, pathology and prognosis of renal disease in type 2 diabetes. BMJ Open Diabetes Res Care 2017;5:e000412. [PMID: 28878938 DOI: 10.1136/bmjdrc-2017-000412] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
85 Cornelius BW. Patients With Type 2 Diabetes: Anesthetic Management in the Ambulatory Setting. Part 1: Pathophysiology and Associated Disease States. Anesth Prog 2016;63:208-15. [PMID: 27973934 DOI: 10.2344/0003-3006-63.4.208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
86 Albu JB, Sohler N, Li R, Li X, Young E, Gregg EW, Ross-Degnan D. An Interrupted Time Series Analysis to Determine the Effect of an Electronic Health Record-Based Intervention on Appropriate Screening for Type 2 Diabetes in Urban Primary Care Clinics in New York City. Diabetes Care 2017;40:1058-64. [PMID: 28620094 DOI: 10.2337/dc16-2133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
87 Sherman RP, Ganguli I. Primary Care-Based Health Coaching for the Management of Prediabetes. Am J Lifestyle Med 2018;12:175-8. [PMID: 30202390 DOI: 10.1177/1559827617702074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
88 Wang HB, Yan WH, Dou JT, Lu ZH, Wang BA, Mu YM. Association between Self-reported Snoring and Prediabetes among Adults Aged 40 Years and Older without Diabetes. Chin Med J (Engl) 2017;130:791-7. [PMID: 28345542 DOI: 10.4103/0366-6999.202741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
89 Dissanayake AM, Wheldon MC, Ahmed J, Hood CJ. Extending Metformin Use in Diabetic Kidney Disease: A Pharmacokinetic Study in Stage 4 Diabetic Nephropathy. Kidney Int Rep 2017;2:705-12. [PMID: 29318219 DOI: 10.1016/j.ekir.2017.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
90 Featherstone T, Eurich DT, Simpson SH. Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors' Facility Residents. Value Health 2017;20:329-35. [PMID: 28292477 DOI: 10.1016/j.jval.2016.09.2403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
91 Nah EH, Cho S, Kim S, Cho HI. Comparison of Urine Albumin-to-Creatinine Ratio (ACR) Between ACR Strip Test and Quantitative Test in Prediabetes and Diabetes. Ann Lab Med 2017;37:28-33. [PMID: 27834062 DOI: 10.3343/alm.2017.37.1.28] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
92 Choi JW, Moon S, Jang EJ, Lee CH, Park JS. Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria. PLoS One 2017;12:e0171367. [PMID: 28158221 DOI: 10.1371/journal.pone.0171367] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
93 Kowall B, Rathmann W, Stang A, Bongaerts B, Kuss O, Herder C, Roden M, Quante A, Holle R, Huth C, Peters A, Meisinger C. Perceived risk of diabetes seriously underestimates actual diabetes risk: The KORA FF4 study. PLoS One 2017;12:e0171152. [PMID: 28141837 DOI: 10.1371/journal.pone.0171152] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
94 Surana S, Kumar N, Vasudeva A, Shaikh G, Jhaveri KD, Shah H, Malieckal D, Fogel J, Sidhu G, Rubinstein S. Awareness and knowledge among internal medicine house-staff for dose adjustment of commonly used medications in patients with CKD. BMC Nephrol 2017;18:26. [PMID: 28095816 DOI: 10.1186/s12882-017-0443-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
95 Exume AA. Perioperative Planning Assessment and Preparation. Surgical Aspects of Peritoneal Dialysis 2017. [DOI: 10.1007/978-3-319-52821-2_4] [Reference Citation Analysis]
96 Gann D. Successful Symbiotic Partnership between Primary Care Physicians and a Disease Management Program in the Treatment of Prediabetes. JDMDC 2016;3. [DOI: 10.15406/jdmdc.2016.03.00089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
97 Losito A, Pittavini L, Zampi I, Zampi E. Characteristics of the Relationship of Kidney Dysfunction with Cardiovascular Disease in High Risk Patients with Diabetes. Int J Nephrol 2016;2016:7180784. [PMID: 27885341 DOI: 10.1155/2016/7180784] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
98 Ward F, Holian J, Murray PT. Drug therapies to delay the progression of chronic kidney disease. Clin Med (Lond) 2015;15:550-7. [PMID: 26621944 DOI: 10.7861/clinmedicine.15-6-550] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
99 Kumar R, Nandhini LP, Kamalanathan S, Sahoo J, Vivekanadan M. Evidence for current diagnostic criteria of diabetes mellitus. World J Diabetes 2016; 7(17): 396-405 [PMID: 27660696 DOI: 10.4239/wjd.v7.i17.396] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
100 Singh-Franco D, Harrington C, Tellez-Corrales E. An updated systematic review and meta-analysis on the efficacy and tolerability of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes with moderate to severe chronic kidney disease. SAGE Open Med 2016;4:2050312116659090. [PMID: 27516879 DOI: 10.1177/2050312116659090] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
101 Ceriello A, Inagaki N. Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations. J Diabetes Investig. 2017;8:19-28. [PMID: 27180612 DOI: 10.1111/jdi.12528] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
102 Davies M, Chatterjee S, Khunti K. The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. Clin Pharmacol 2016;8:61-81. [PMID: 27382338 DOI: 10.2147/CPAA.S82008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
103 Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI. Clinical predictive factors in diabetic kidney disease progression. J Diabetes Investig 2017;8:6-18. [PMID: 27181363 DOI: 10.1111/jdi.12533] [Cited by in Crossref: 86] [Cited by in F6Publishing: 95] [Article Influence: 14.3] [Reference Citation Analysis]
104 Cauchi S. De nouveaux facteurs génétiques associés à l’albuminurie chez les diabétiques. Médecine des Maladies Métaboliques 2016;10:47-48. [DOI: 10.1016/s1957-2557(16)30091-8] [Reference Citation Analysis]
105 Obayashi K, Saeki K, Kurumatani N. Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study. Clin J Am Soc Nephrol 2016;11:867-74. [PMID: 26915915 DOI: 10.2215/CJN.07700715] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
106 Wu B, Bell K, Stanford A, Kern DM, Tunceli O, Vupputuri S, Kalsekar I, Willey V. Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012. BMJ Open Diabetes Res Care 2016;4:e000154. [PMID: 27110365 DOI: 10.1136/bmjdrc-2015-000154] [Cited by in Crossref: 80] [Cited by in F6Publishing: 88] [Article Influence: 13.3] [Reference Citation Analysis]
107 Lai S. Chronic Kidney Disease and Diabetes-A Potential Causal Link. EBioMedicine 2016;6:10-1. [PMID: 27211535 DOI: 10.1016/j.ebiom.2016.03.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
108 Ballotari P, Roncaglia F, Chiatamone Ranieri S, Greci M, Manicardi V, Giorgi Rossi P. Diagnostic values of glycated haemoglobin and diagnosis of diabetes: Results of a cross-sectional survey among general practitioners in the province of Reggio Emilia, Italy. J Clin Transl Endocrinol 2016;3:21-5. [PMID: 29159124 DOI: 10.1016/j.jcte.2016.01.001] [Reference Citation Analysis]
109 Yamada S. Impaired Parathyroid Function and Bone Formation: A Risk for Development of Adynamic Bone Disease to Enhance Vascular Calcification. Musculoskeletal Disease Associated with Diabetes Mellitus 2016. [DOI: 10.1007/978-4-431-55720-3_7] [Reference Citation Analysis]
110 Kang SH, Jung da J, Choi EW, Cho KH, Park JW, Do JY. HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011-2013). PLoS One. 2015;10:e0145827. [PMID: 26716684 DOI: 10.1371/journal.pone.0145827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
111 Okwechime IO, Roberson S, Odoi A. Prevalence and Predictors of Pre-Diabetes and Diabetes among Adults 18 Years or Older in Florida: A Multinomial Logistic Modeling Approach. PLoS One 2015;10:e0145781. [PMID: 26714019 DOI: 10.1371/journal.pone.0145781] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
112 Teumer A, Tin A, Sorice R, Gorski M, Yeo NC, Chu AY, Li M, Li Y, Mijatovic V, Ko YA, Taliun D, Luciani A, Chen MH, Yang Q, Foster MC, Olden M, Hiraki LT, Tayo BO, Fuchsberger C, Dieffenbach AK, Shuldiner AR, Smith AV, Zappa AM, Lupo A, Kollerits B, Ponte B, Stengel B, Krämer BK, Paulweber B, Mitchell BD, Hayward C, Helmer C, Meisinger C, Gieger C, Shaffer CM, Müller C, Langenberg C, Ackermann D, Siscovick D, Boerwinkle E, Kronenberg F, Ehret GB, Homuth G, Waeber G, Navis G, Gambaro G, Malerba G, Eiriksdottir G, Li G, Wichmann HE, Grallert H, Wallaschofski H, Völzke H, Brenner H, Kramer H, Mateo Leach I, Rudan I, Hillege HL, Beckmann JS, Lambert JC, Luan J, Zhao JH, Chalmers J, Coresh J, Denny JC, Butterbach K, Launer LJ, Ferrucci L, Kedenko L, Haun M, Metzger M, Woodward M, Hoffman MJ, Nauck M, Waldenberger M, Pruijm M, Bochud M, Rheinberger M, Verweij N, Wareham NJ, Endlich N, Soranzo N, Polasek O, van der Harst P, Pramstaller PP, Vollenweider P, Wild PS, Gansevoort RT, Rettig R, Biffar R, Carroll RJ, Katz R, Loos RJ, Hwang SJ, Coassin S, Bergmann S, Rosas SE, Stracke S, Harris TB, Corre T, Zeller T, Illig T, Aspelund T, Tanaka T, Lendeckel U, Völker U, Gudnason V, Chouraki V, Koenig W, Kutalik Z, O'Connell JR, Parsa A, Heid IM, Paterson AD, de Boer IH, Devuyst O, Lazar J, Endlich K, Susztak K, Tremblay J, Hamet P, Jacob HJ, Böger CA, Fox CS, Pattaro C, Köttgen A; DCCT/EDIC. Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes. Diabetes 2016;65:803-17. [PMID: 26631737 DOI: 10.2337/db15-1313] [Cited by in Crossref: 108] [Cited by in F6Publishing: 108] [Article Influence: 15.4] [Reference Citation Analysis]
113 Lee YH, Armstrong EJ, Kim G, Oh J, Kang SM, Lee BW, Ahn CW, Cha BS, Lee HC, Mantzoros CS, Kang ES. Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes. Am Heart J 2015;170:760-769.e2. [PMID: 26386800 DOI: 10.1016/j.ahj.2015.07.024] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
114 Dinar Y, Elkhoudri N, Belahsen R. Effect of education on nutrition and diabetes status in type 2 diabetics in El Jadida province of Morocco. MNM 2015;8:187-97. [DOI: 10.3233/mnm-150040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
115 Zenteno-Castillo P, Muñoz-López DB, Merino-Reyes B, Vega-Sánchez Á, Preciado-Puga M, González-Yebra AL, Kornhauser C. Prevalence of diabetic nephropathy in Type 2 Diabetes Mellitus in rural communities of Guanajuato, Mexico. Effect after 6 months of Telmisartan treatment. J Clin Transl Endocrinol 2015;2:125-8. [PMID: 29159116 DOI: 10.1016/j.jcte.2015.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
116 Piccoli GB, Grassi G, Cabiddu G, Nazha M, Roggero S, Capizzi I, De Pascale A, Priola AM, Di Vico C, Maxia S, Loi V, Asunis AM, Pani A, Veltri A. Diabetic Kidney Disease: A Syndrome Rather Than a Single Disease. Rev Diabet Stud. 2015;12:87-109. [PMID: 26676663 DOI: 10.1900/rds.2015.12.87] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
117 Prasannakumar M, Rajput R, Seshadri K, Talwalkar P, Agarwal P, Gokulnath G, Kotak B, Raza A, Vasnawala H, Teli C. An observational, cross-sectional study to assess the prevalence of chronic kidney disease in type 2 diabetes patients in India (START -India). Indian J Endocrinol Metab 2015;19:520-3. [PMID: 26180769 DOI: 10.4103/2230-8210.157857] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
118 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
119 Unni S, White K, Goodman M, Ye X, Mavros P, Bash LD, Brixner D. Hypertension control and antihypertensive therapy in patients with chronic kidney disease. Am J Hypertens 2015;28:814-22. [PMID: 25421796 DOI: 10.1093/ajh/hpu215] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
120 Inagaki N, Kondo K, Yoshinari T, Ishii M, Sakai M, Kuki H, Furihata K. Pharmacokinetic and pharmacodynamic profiles of canagliflozin in Japanese patients with type 2 diabetes mellitus and moderate renal impairment. Clin Drug Investig 2014;34:731-42. [PMID: 25200141 DOI: 10.1007/s40261-014-0226-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
121 Jadhakhan F, Marshall T, Gill P. A systematic review investigating the cumulative incidence of chronic kidney disease in young adults with impaired glucose tolerance. Syst Rev 2015;4:69. [PMID: 25968063 DOI: 10.1186/s13643-015-0059-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
122 Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J 2014;18:88-93. [PMID: 25102521 DOI: 10.7812/TPP/14-002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 90] [Article Influence: 15.4] [Reference Citation Analysis]
123 Bullard KM, Ali MK, Imperatore G, Geiss LS, Saydah SH, Albu JB, Cowie CC, Sohler N, Albright A, Gregg EW. Receipt of Glucose Testing and Performance of Two US Diabetes Screening Guidelines, 2007-2012. PLoS One 2015;10:e0125249. [PMID: 25928306 DOI: 10.1371/journal.pone.0125249] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
124 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 242] [Cited by in F6Publishing: 256] [Article Influence: 34.6] [Reference Citation Analysis]
125 Maniglia FP, Alberto dos Santos RM, Cardeal da Costa JA. The Role of Nutrition and Supplementation in Dialysis Patient Health. Glucose Intake and Utilization in Pre-Diabetes and Diabetes 2015. [DOI: 10.1016/b978-0-12-800093-9.00027-2] [Reference Citation Analysis]
126 Agu U, Agu MC, Nnaji GA. Assessment of risk of developing diabetes mellitus among local government employees in Onitsha, south-eastern Nigeria. Epidemiol Rep 2015;3:4. [DOI: 10.7243/2054-9911-3-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
127 Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine 2015;48:371-93. [PMID: 25294012 DOI: 10.1007/s12020-014-0436-2] [Cited by in Crossref: 89] [Cited by in F6Publishing: 73] [Article Influence: 11.1] [Reference Citation Analysis]
128 Xing FY, Neeland IJ, Gore MO, Ayers CR, Paixao AR, Turer AT, Berry JD, Khera A, de Lemos JA, McGuire DK. Association of prediabetes by fasting glucose and/or haemoglobin A1c levels with subclinical atherosclerosis and impaired renal function: observations from the Dallas Heart Study. Diab Vasc Dis Res 2014;11:11-8. [PMID: 24344119 DOI: 10.1177/1479164113514239] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
129 Charles LE, Gu JK, Fekedulegn D, Andrew ME, Violanti JM, Burchfiel CM. Association between shiftwork and glomerular filtration rate in police officers. J Occup Environ Med 2013;55:1323-8. [PMID: 24164760 DOI: 10.1097/JOM.0b013e3182a299c9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
130 Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, Bhuiyan AR, Jenkins BC, Addison C. The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study. PLoS One 2014;9:e101610. [PMID: 24991817 DOI: 10.1371/journal.pone.0101610] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
131 Bailey RA, Wang Y, Zhu V, Rupnow MF. Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging. BMC Res Notes 2014;7:415. [PMID: 24990184 DOI: 10.1186/1756-0500-7-415] [Cited by in Crossref: 151] [Cited by in F6Publishing: 159] [Article Influence: 18.9] [Reference Citation Analysis]
132 Mainous AG 3rd, Tanner RJ, Baker R, Zayas CE, Harle CA. Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study. BMJ Open 2014;4:e005002. [PMID: 24913327 DOI: 10.1136/bmjopen-2014-005002] [Cited by in Crossref: 114] [Cited by in F6Publishing: 119] [Article Influence: 14.3] [Reference Citation Analysis]
133 Li C, Wen XJ, Pavkov ME, Zhao G, Balluz LS, Ford ES, Williams D, Gotway CA. Awareness of kidney disease among US adults: Findings from the 2011 behavioral risk factor surveillance system. Am J Nephrol 2014;39:306-13. [PMID: 24732234 DOI: 10.1159/000360184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
134 Groop PH, Del Prato S, Taskinen MR, Owens DR, Gong Y, Crowe S, Patel S, von Eynatten M, Woerle HJ. Linagliptin treatment in subjects with type 2 diabetes with and without mild-to-moderate renal impairment. Diabetes Obes Metab 2014;16:560-8. [PMID: 24612167 DOI: 10.1111/dom.12281] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
135 Portero McLellan KC, Wyne K, Villagomez ET, Hsueh WA. Therapeutic interventions to reduce the risk of progression from prediabetes to type 2 diabetes mellitus. Ther Clin Risk Manag 2014;10:173-88. [PMID: 24672242 DOI: 10.2147/TCRM.S39564] [Cited by in Crossref: 9] [Cited by in F6Publishing: 36] [Article Influence: 1.1] [Reference Citation Analysis]
136 Lee LT, Alexandrov AW, Howard VJ, Kabagambe EK, Hess MA, McLain RM, Safford MM, Howard G. Race, regionality and pre-diabetes in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Prev Med 2014;63:43-7. [PMID: 24594101 DOI: 10.1016/j.ypmed.2014.02.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
137 Hamm LL, Thethi TK, Hering-smith KS. Cardiovascular Disease in Diabetic Nephropathy. Diabetes and Kidney Disease 2014. [DOI: 10.1007/978-1-4939-0793-9_11] [Reference Citation Analysis]
138 Cohen EP, Krzesinski J. Screening, Early Diagnosis, Genetic Markers, and Predictors of Diabetic Nephropathy. Diabetes and Kidney Disease 2014. [DOI: 10.1007/978-1-4939-0793-9_7] [Reference Citation Analysis]
139 El-Eshmawy MM, Abd El-Hafez HA, El Shabrawy WO, Abdel Aal IA. Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic egyptian adults. Diabetes Metab J 2013;37:450-7. [PMID: 24404516 DOI: 10.4093/dmj.2013.37.6.450] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
140 Kountz D. The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups. Adv Ther 2013;30:1067-85. [PMID: 24287690 DOI: 10.1007/s12325-013-0071-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
141 Zhou Y, Echouffo-Tcheugui JB, Gu JJ, Ruan XN, Zhao GM, Xu WH, Yang LM, Zhang H, Qiu H, Narayan KM. Prevalence of chronic kidney disease across levels of glycemia among adults in Pudong New Area, Shanghai, China. BMC Nephrol. 2013;14:253. [PMID: 24238578 DOI: 10.1186/1471-2369-14-253] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
142 von Websky K, Reichetzeder C, Hocher B. Linagliptin as add-on therapy to insulin for patients with type 2 diabetes. Vasc Health Risk Manag 2013;9:681-94. [PMID: 24204157 DOI: 10.2147/VHRM.S40035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
143 Janmohamed MN, Kalluvya SE, Mueller A, Kabangila R, Smart LR, Downs JA, Peck RN. Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol 2013;14:183. [PMID: 24228774 DOI: 10.1186/1471-2369-14-183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
144 Hernandez D, Espejo-Gil A, Bernal-Lopez MR, Mancera-Romero J, Baca-Osorio AJ, Tinahones FJ, Armas-Padron AM, Ruiz-Esteban P, Torres A, Gomez-Huelgas R. Association of HbA1c and cardiovascular and renal disease in an adult Mediterranean population. BMC Nephrol 2013;14:151. [PMID: 23865389 DOI: 10.1186/1471-2369-14-151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
145 Buysschaert M, Bergman M. Diagnosis of Prediabetes and Diabetes Prevention. Prevention of Diabetes 2013. [DOI: 10.1002/9781118661321.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
146 Lucas R, Parikh SJ, Sridhar S, Guo DH, Bhagatwala J, Dong Y, Caldwell R, Mellor A, Caldwell W, Zhu H, Dong Y. Cytokine profiling of young overweight and obese female African American adults with prediabetes. Cytokine 2013;64:310-5. [PMID: 23769592 DOI: 10.1016/j.cyto.2013.05.025] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
147 Hadigan C, Edwards E, Rosenberg A, Purdy JB, Fleischman E, Howard L, Mican JM, Sampath K, Oyalowo A, Johnson A, Adler A, Rehm C, Smith M, Lai L, Kopp JB. Microalbuminuria in HIV disease. Am J Nephrol 2013;37:443-51. [PMID: 23615312 DOI: 10.1159/000350384] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
148 Grandfils N, Detournay B, Attali C, Joly D, Simon D, Vergès B, Toussi M, Briand Y, Delaitre O. Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in france: a cross-sectional study. Int J Endocrinol 2013;2013:640632. [PMID: 23653644 DOI: 10.1155/2013/640632] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
149 Rodriguez-Poncelas A, Garre-Olmo J, Franch-Nadal J, Diez-Espino J, Mundet-Tuduri X, Barrot-De la Puente J, Coll-de Tuero G; RedGDPS Study Group. Prevalence of chronic kidney disease in patients with type 2 diabetes in Spain: PERCEDIME2 study. BMC Nephrol 2013;14:46. [PMID: 23433046 DOI: 10.1186/1471-2369-14-46] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 8.1] [Reference Citation Analysis]
150 Khunti K, Morris DH, Weston CL, Gray LJ, Webb DR, Davies MJ. Joint prevalence of diabetes, impaired glucose regulation, cardiovascular disease risk and chronic kidney disease in South Asians and White Europeans. PLoS One 2013;8:e55580. [PMID: 23383233 DOI: 10.1371/journal.pone.0055580] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
151 Little JW, Falace DA, Miller CS, Rhodus NL. Chronic Kidney Disease and Dialysis. Little and Falace's Dental Management of the Medically Compromised Patient 2013. [DOI: 10.1016/b978-0-323-08028-6.00012-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
152 Icks A, Koch M. Epidemiology of Chronic Kidney Disease in Diabetes. Diabetes and Kidney Disease 2012. [DOI: 10.1002/9781118494073.ch2] [Reference Citation Analysis]
153 Juutilainen A, Kastarinen H, Antikainen R, Peltonen M, Salomaa V, Tuomilehto J, Jousilahti P, Sundvall J, Laatikainen T, Kastarinen M. Trends in estimated kidney function: the FINRISK surveys. Eur J Epidemiol 2012;27:305-13. [PMID: 22286717 DOI: 10.1007/s10654-012-9652-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
154 Bloomgarden ZT. Diabetes: East meets West. The Joint American Association of Clinical Endocrinologists-Chinese Society of Endocrinology (AACE-CSE) Symposium. J Diabetes 2012;4:221-6. [PMID: 22898104 DOI: 10.1111/j.1753-0407.2012.00228.x] [Reference Citation Analysis]
155 Alshaarawy O, Teppala S, Shankar A. Markers of Sleep-Disordered Breathing and Prediabetes in US Adults. Int J Endocrinol 2012;2012:902324. [PMID: 22829819 DOI: 10.1155/2012/902324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
156 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
157 Shevalye H, Lupachyk S, Watcho P, Stavniichuk R, Khazim K, Abboud HE, Obrosova IG. Prediabetic nephropathy as an early consequence of the high-calorie/high-fat diet: relation to oxidative stress. Endocrinology 2012;153:1152-61. [PMID: 22234462 DOI: 10.1210/en.2011-1997] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
158 Kim JH, Kim DJ, Jang HC, Choi SH. Epidemiology of micro- and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J 2011;35:571-7. [PMID: 22247898 DOI: 10.4093/dmj.2011.35.6.571] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
159 Bloomgarden ZT. Focus on Incretin-Based Therapies for Patients with Type 2 Diabetes and Renal Insufficiency. Endocrine Practice 2011;17:5-8. [DOI: 10.1016/s1530-891x(20)43145-3] [Reference Citation Analysis]
160 Bakris GL. Recognition, pathogenesis, and treatment of different stages of nephropathy in patients with type 2 diabetes mellitus. Mayo Clin Proc 2011;86:444-56. [PMID: 21531886 DOI: 10.4065/mcp.2010.0713] [Cited by in Crossref: 73] [Cited by in F6Publishing: 87] [Article Influence: 6.6] [Reference Citation Analysis]
161 Tuot DS, Plantinga LC, Hsu CY, Jordan R, Burrows NR, Hedgeman E, Yee J, Saran R, Powe NR; Centers for Disease Control Chronic Kidney Disease Surveillance Team. Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol. 2011;6:1838-1844. [PMID: 21784832 DOI: 10.2215/cjn.00730111] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
162 Barnett AH. Linagliptin: a novel dipeptidyl peptidase 4 inhibitor with a unique place in therapy. Adv Ther 2011;28:447-59. [PMID: 21603986 DOI: 10.1007/s12325-011-0028-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
163 Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I, Eriksen BO. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care. 2011;34:1546-1551. [PMID: 21593291 DOI: 10.2337/dc11-0235] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 8.5] [Reference Citation Analysis]